Abstract
Hypoxic conditions in the pancreatic tumor microenvironment lead to the stabilization of hypoxia-inducible factor-1 alpha (HIF-1α), which acts as the master regulator of cancer cell metabolism. HIF-1α-mediated metabolic reprogramming results in large-scale metabolite perturbations. Characterization of the metabolic intermediates and the corresponding metabolic pathways altered by HIF-1α would facilitate the identification of therapeutic targets for hypoxic microenvironments prevalent in pancreatic ductal adenocarcinoma and other solid tumors. Targeted metabolomic approaches are versatile in quantifying multiple metabolite levels in a single platform and, thus, enable the characterization of multiple metabolite alterations regulated by HIF-1α. In this chapter, we describe a detailed metabolomic approach for characterizing the hypoxia-induced metabolomic alterations using pancreatic cancer cell lines cultured in normoxic and hypoxic conditions. We elaborate the methodology of cell culture, hypoxic exposure, metabolite extraction, and relative quantification of polar metabolites from normoxia- and hypoxia-exposed cell extracts, using a liquid chromatography-coupled tandem mass spectrometry approach. Herein, using our metabolomic data, we also present the methods for metabolomic data representation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Whatcoff CJ, Diep CH, Jiang P, Watanabe A, LoBello J, Sima C, Hostetter G, Shepard HM, Von Hoff DD, Han H (2015) Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer. Clin Cancer Res 21(15):3561–3568. http://doi: 10.1158/1078-0432
Mehla K, Singh PK (2014) MUC1: a novel metabolic master regulator. Biochim Biophys Acta 1845(2):126–135. http://doi: 10.1016/j.bbcan.2014.01.001
Chaika NV, Gebregiworgis T, Lewallen ME, Purohit V, Radhakrishnan P, Liu X, Zhang B, Mehla K, Brown RB, Caffrey T, Yu F, Johnson KR, Powers R, Hollingsworth MA, Singh PK. (2012) MUC1 mucin stabilizes and activates hypoxia-inducible factor 1 alpha to regulate metabolism in pancreatic cancer. Proc Natl Acad Sci U S A 109(34):13787–13792. http://doi: 10.1073/pnas.1203339109
Byrne MB, Leslie MT, Gaskins HR, Kenia PJA (2014) Methods to study the tumor microenvironment under controlled oxygen conditions. Trends Biotechnol 32(11):556–563. http://:doi: 10.1016/j.tibtech.2014.09.006
Hsu SH, Chen CT, Wei YH (2013) Inhibitory effects of hypoxia on metabolic switch and osteogenic differentiation of human mesenchymal stem cells. Stem Cells 31(12):2779–2788. http://doi: 10.1002/stem.1441
Solaini G, Baracca A, Lenaz G, Sgarbi G (2010) Hypoxia and mitochondrial oxidative metabolism. Biochim Biophys Acta 1797(6–7):1171–1177. http://doi: 10.1016/j.bbabio.2010.02.011
Jiang J, Auchinvole C, Fisher K, Campbell CJ (2014) Quantitative measurement of redox potential in hypoxic cells using SERS nanosensors. Nanoscale 6(20):12104–12110. http://doi: 10.1039/c4nr01263a
Winer PLS, Wu M (2014) Rapid analysis of glycolytic and oxidative substrate flux of cancer cells in a microplate. PLoS One 9(10):e109916. http://doi: 10.1371/journal.pone.0109916
Feala JD, Coquin L, Zhou D, Haddad GG, Paternostro G, McCulloch AD (2009) Metabolism as means for hypoxia adaptation: metabolic profiling and flux balance analysis. BMC Syst Biol 3:91. http://doi: 10.1186/1752-0509-3-91
Gunda V, Yu F, Singh PK (2016) Validation of metabolic alterations in microscale cell culture lysates using hydrophilic interaction liquid chromatography (HILIC)-tandem mass spectrometry-based metabolomics. PLoS One 11(4):e0154416.https://doi.org/10.1371/journal.pone.0154416
Shukla SK, Purohit V, Mehla K, Gunda V, Chaika NV, Vernucci E, King RJ, Abrego J, Goode GD, Dasgupta A, Illies AL, Gebregiworgis T, Dai B, Augustine JJ, Murthy D, Attri KS, Mashadova O, Grandgenett PM, Powers R, Ly QP, Lazenby AJ, Grem JL, Yu F, Matés JM, Asara JM, Kim J, Hankins JH, Weekes C, Hollingsworth MA, Serkova NJ, Sasson AR, Fleming JB, Oliveto JM, Lyssiotis CA, Cantley LC, Berim l, Singh PK (2017) MUC1 and HIF-1alpha Signaling Crosstalk Induces Anabolic Glucose Metabolism to Impart Gemcitabine Resistance to Pancreatic Cancer. Cancer Cell 32(1):71–87.e7. http://doi: 10.1016/j.ccell.2017.06.004
Gunda V, Souchek J, Abrego J, Shukla SK, Goode GD, Vernucci E, Dasgupta A, Chaika NV, King RJ, Li S, Wang S, Yu F, Bessho T, Lin C, Singh PK (2017) MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer. Clinical Cancer Research 23(19):5881–5891. http://doi: 10.1158/1078-0432.CCR-17-1151
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gunda, V., Kumar, S., Dasgupta, A., Singh, P.K. (2018). Hypoxia-Induced Metabolomic Alterations in Pancreatic Cancer Cells. In: Huang, L. (eds) Hypoxia. Methods in Molecular Biology, vol 1742. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7665-2_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7665-2_9
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7664-5
Online ISBN: 978-1-4939-7665-2
eBook Packages: Springer Protocols